Autoimmune Lymphoproliferative Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Approaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative Syndrome.
|
26258116 |
2015 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
SomaticCausalMutation
|
disease |
ORPHANET |
The diagnosis of autoimmune lymphoproliferative syndrome had been delayed for a variety of reasons, including unusual clinical manifestations, late referral to a reference center, and the occurrence of somatic FAS mutations.
|
22983577 |
2013 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GermlineCausalMutation
|
disease |
ORPHANET |
The diagnosis of autoimmune lymphoproliferative syndrome had been delayed for a variety of reasons, including unusual clinical manifestations, late referral to a reference center, and the occurrence of somatic FAS mutations.
|
22983577 |
2013 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
SomaticCausalMutation
|
disease |
ORPHANET |
The majority of ALPS patients carry heterozygous germline (ALPS-FAS) or somatic mutations (ALPS-sFAS) of the TNFRSF6 gene coding for FAS.
|
21885602 |
2011 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GermlineCausalMutation
|
disease |
ORPHANET |
The majority of ALPS patients carry heterozygous germline (ALPS-FAS) or somatic mutations (ALPS-sFAS) of the TNFRSF6 gene coding for FAS.
|
21885602 |
2011 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations.
|
20935634 |
2010 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
Biomarker
|
disease |
CTD_human |
Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.
|
17674358 |
2007 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation.
|
17336828 |
2007 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
Biomarker
|
disease |
CTD_human |
Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
|
15877736 |
2005 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
|
11418480 |
2001 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
|
10090885 |
1999 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
We describe the molecular analysis of the CD95 death domain in a family with autoimmune lymphoproliferative syndrome (Canale-Smith syndrome), T-cell lymphoma, and Hodgkin's disease.
|
10340403 |
1999 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations.
|
9927496 |
1999 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Fas (CD95/Apo-1) mutations were previously reported as the genetic defect responsible for human lymphoproliferative syndrome associated with autoimmune manifestations (also known as autoimmune lymphoproliferative syndrome or Canale-Smith syndrome).
|
10515860 |
1999 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.
|
9821419 |
1998 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.
|
9028321 |
1997 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
One ALPS patient lacked a Fas gene mutation.
|
9028957 |
1997 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Inherited mutations of the Fas/Apo1/CD95 gene, a cell-surface receptor involved in cell death signaling and in the control of self-reactivity, characterize the recently identified autoimmune lymphoproliferative syndromes.
|
9322534 |
1997 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.
|
8929361 |
1996 |
Autoimmune Lymphoproliferative Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
|
7540117 |
1995 |
Squamous cell carcinoma
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Squamous cell carcinoma
|
0.600 |
CausalMutation
|
disease |
CGI |
|
|
|
Lymphoma, Non-Hodgkin
|
0.540 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Lymphoma, Non-Hodgkin
|
0.540 |
CausalMutation
|
disease |
CGI |
|
|
|
Cardiomyopathy, Dilated
|
0.510 |
Biomarker
|
group |
CTD_human |
Myocardial Fas ligand expression increases susceptibility to AZT-induced cardiomyopathy.
|
17943461 |
2007 |